According to MyBio, the test kit provides excellent diagnostic specificity and sensitivity for both the IgG and IgM antibodies.
Their presence will indicate whether you have been exposed to the virus previously. The test's ability to detect either (or both) antibodies makes it one of the most accurate on the market.
MyBio believe the test can play a crucial role as the lockdown eases and more people return to work.
"We anticipate strong demand for this kit from corporations, businesses, professional laboratories, and other life science companies and institutes across the country and the EU," said Dan Dilks, the company's head of sales and business development. "If offered by their employer, this test kit will provide an important and simple pre-screening service for employees in Ireland, which will prove an invaluable tool in the fight against COVID-19 in the coming months as people return to work and wish to know if they've been exposed."
Currently available for professional use, the test kit provides a quick, on-the-spot result in 10 minutes. It's easy to use, needing only a finger-prick sample much like a blood glucose test. The test can also be run with serum or plasma samples.
Unlike the test to determine if somebody is currently carrying the virus, antibody testing determines if a person has had the infection in the past. This is done by detecting the presence of antibodies produced by the immune system against COVID-19.
A recent study in Heinsberg, Germany has suggested that the coronavirus infection rate could be much higher than initially thought.
The research showed that close to a quarter of those tested were asymptomatic showing no signs of having caught the virus. MyBio's test kit will help diagnose such cases, on-site and quickly.
As a result of the new partnership, MyBio Ltd will provide marketing, sales, customer service and technical support for the sale of MöLab`s Covid-19 antibody diagnostic kit. The kit is available to order now from and ships to the UK and EU.
MyBio is based in Kilkenny, and is a leading distributor to the research, pharmaceutical and diagnostic testing laboratories in Ireland. They have been in business for more than 10 years and was the overall winner of the Ireland's National Enterprise Award in 2015.
The company is certified as a diversity supplier by WEConnect International.
MöLab GmbH was established in 1985. For more than 35 years, the company has been pioneering new and modern ways to manufacture point of care diagnostics.
Their products and services serve doctors, hospitals, public institutions, and security-related authorities.
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal
NJ Bio and Aji Bio-Pharma partner to strengthen support for ADC development
Alltrna granted approval for first-in-human clinical trial of AP003
Lilly to acquire Centessa Pharmaceuticals for up to USD47 per share
Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management
AstraZeneca reports positive phase III results for efzimfotase alfa in hypophosphatasia
Galapagos and Gilead expand collaboration to advance T cell engager programme
Sanofi secures EU approval for Rezurock in chronic graft-versus-host disease
Delonix Bioworks launches Phase 1 trial of next-generation MenB OMV vaccine DX-104
Hengrui Pharma and Braveheart Bio report positive Phase 2 results for HRS/BHB-1893 in oHCM
Innovent and Ollin Biosciences report IBI324 study data in wAMD and DME
Fusion Antibodies signs GBP250,000 IP transfer deal with Finn Therapeutics